10 at 10: These ASX stocks are steaming ahead this morning
The Flying Scotsman steam train is seen after crossing the Forth Bridge, as it makes a journey towards Edinburgh (Pic: Getty)
Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data.
It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has commenced trading.
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Code | Company | Price | % | Volume |
|---|---|---|---|---|
| ANL | Amani Gold Ltd | 0.002 | 100 | 3825000 |
| HYD | Hydrix Limited | 0.24 | 55 | 2881400 |
| CLZ | Classic Min Ltd | 0.0015 | 50 | 13912550 |
| AT1 | Atomo Diagnostics | 0.2 | 48 | 7342209 |
| ECT | Env Clean Tech Ltd. | 0.002 | 33 | 1650871 |
| DCX | Discovex Res Ltd | 0.006 | 20 | 1593155 |
| YOJ | Yojee Limited | 0.16 | 19 | 1369592 |
| GES | Genesis Resources | 0.015 | 15 | 485000 |
| NMR | Native Mineral Res | 0.31 | 15 | 83450 |
| NUS | Nusantara Resources | 0.345 | 13 | 219230 |
Atomo Diagnostics (ASX:AT1) had a jointly developed COVID-19 test approved by the FDA.
Hydrix (ASX:HYD) also got FDA approval for its medical device, namely the heart monitoring device AngelMed Guardian.
In resources, Indonesia focused gold play Nusantara Resources (ASX:NUS) got a takeover offer.
| Code | Company | Price | % | Volume |
|---|---|---|---|---|
| CYC | Cyclopharm Limited | 1.8 | -34 | 79246 |
| NPM | Newpeak Metals | 0.0015 | -25 | 3494000 |
| MRD | Mount Ridley Mines | 0.0025 | -17 | 5260500 |
| MRQ | Mrg Metals Limited | 0.006 | -14 | 82000 |
| CY5 | Cygnus Gold Limited | 0.1 | -13 | 83000 |
| ADV | Ardiden Ltd | 0.008 | -11 | 2112712 |
| IVT | Inventis Limited | 0.008 | -11 | 500000 |
| PNX | PNX Metals Limited | 0.008 | -11 | 499000 |
| MCT | Metalicity Limited | 0.009 | -10 | 140000 |
| ASO | Aston Minerals Ltd | 0.155 | -9 | 263504 |
Cyclopharm (ASX:CYC) however got the cold shoulder from the FDA in relation to Technegas – its radioactive lung imaging agent.
Related Stories
UNLOCK INSIGHTS
Discover the untold stories of emerging ASX stocks.
Daily news and expert analysis, it's free to subscribe.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.
